Stratipath, a spin-out from the Karolinska Institutet in Stockholm, is a rapidly growing medical software company improving breast cancer treatment and patient outcomes with a novel and cost-effective AI-based solution. The platform is based on deep technical and medical expertise and a uniquely large population-representative dataset of histopathological images from patients.